USADA announced today that Hamdy Abdelwahab, of Bronx, NY, has accepted a two-year sanction for violating the UFC’s anti-doping policy.
Abdelwahab, 30, tested positive for methenolone (metenolone) and its metabolite (3α-hydroxy-1-methylene-5α-andostan-17-one) following a sample taken in competition on July 30, 2022 , and a sample taken out of competition on August 27, 2022. Because Abdelwahab was not yet notified of his first positive test when his second test was taken, the two positive tests are combined into a single infraction. Methenolone is an unspecified substance of the class of anabolic agents and is prohibited at all times under the UFC Anti-Doping Policy (the Policy) and the UFC Prohibited List.
After being added to the UFC Anti-Doping Program, athletes are required to declare any Prohibited Substances they have used in the previous 12 months and failure to do so, in the absence of compelling justification. , is considered a tampering violation under Section 2.5.2. politics. Abdelwahab did not declare the use of methenolone on his integration declaration forms and did not establish a convincing justification for his failure to do so. Based on USADA’s investigation, it was determined that Abdelwahab had used the banned substance and was aware of his obligation to report it. The evidence constitutes a violation of tampering in addition to the violation of his positive test for methenolone.
Abdelwahab’s two-year period of suspension began July 30, 2022, when his first positive sample was taken. Abdelwahab’s positive test also falls under the jurisdiction of the Texas Department of Licensing and Regulation, which resolves the case according to its rules.
Read the full statement at USADA.org